Home Cart Sign in  
Chemical Structure| 866927-10-8 Chemical Structure| 866927-10-8

Structure of IC87201
CAS No.: 866927-10-8

Chemical Structure| 866927-10-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

IC87201, an inhibitor of PSD95-nNOS protein-protein interactions, suppresses NMDAR-dependent NO and cGMP formation.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of IC87201

CAS No. :866927-10-8
Formula : C13H10Cl2N4O
M.W : 309.15
SMILES Code : OC1=C(Cl)C=C(Cl)C=C1CNC2=CC=C3N=NNC3=C2
MDL No. :MFCD28160570
InChI Key :QEHVTUCLCBXQIC-UHFFFAOYSA-N
Pubchem ID :11771269

Safety of IC87201

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
hippocampal neurons 20 μM 10 minutes suppressed NMDA-stimulated cGMP formation Behav Brain Res. 2016 May 15;305:23-9
cortical neurons 10 µM 20 minutes To evaluate the protective effect of IC87201 against glutamate-induced excitotoxicity. Results showed that pretreatment with IC87201 significantly reduced glutamate/glycine-induced neuronal death, with efficacy comparable to the NMDAR antagonist MK-801. Neuropharmacology. 2015 Oct;97:464-75

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J male mice Formalin-induced pain model Intraperitoneal injection 4 or 10 mg/kg Single administration, observed for 40 minutes To evaluate the analgesic effect of IC87201 in the formalin-induced pain model. Results showed that the high dose of IC87201 (10 mg/kg) significantly suppressed formalin-induced pain behaviors, particularly during phase 2A of the pain response. Neuropharmacology. 2015 Oct;97:464-75
Rats Conditioned place preference (CPP) model Intraperitoneal injection 10 mg/kg Single administration Evaluate the effect of IC87201 on morphine-induced conditioned place preference. IC87201 alone did not produce reward or aversion but blocked morphine-induced CPP. Addict Biol. 2022 Sep;27(5):e13220
Rats Formalin-induced pain model Intraperitoneal injection 4 or 10 mg/kg Single administration, observed for 60 minutes IC87201 and ZL006 (but not ZL007) suppressed phase 2 of formalin-evoked pain behavior and decreased the number of formalin-induced Fos-like immunoreactive cells in spinal dorsal horn regions associated with nociceptive processing. Neuroscience. 2017 May 4;349:303-317
Sprague-Dawley rats Middle cerebral artery occlusion (MCAO) model Intraperitoneal injection 10 mg/kg Single dose IC87201 significantly recovered post-ischemia damages, including neurobehavioral function, reduction of volume of the total hemisphere, cortex, and striatum in rat brain, and the percentage of infarcted areas. Additionally, in the striatum region, IC87201 caused an increase in the total number of neuronal and non-neuronal cells as well as a decrease in the total number of dead cells IBRO Neurosci Rep. 2024 Nov 24;17:463-470
Long-Evans rats Source memory task model Intraperitoneal injection 1, 4 and 10 mg/kg Administered 30 minutes prior to behavioral testing IC87201 and ZL006 at behaviorally effective doses spared source memory, spatial memory, and motor function Behav Brain Res. 2016 May 15;305:23-9

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.23mL

0.65mL

0.32mL

16.17mL

3.23mL

1.62mL

32.35mL

6.47mL

3.23mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories